Deep Track Biotechnology Master Fund, Ltd.

Insider Reports History

Location
C/O Walkers Corporate Limited, 190 Elgin Ave, George Town, Cayman Islands
Signature
Deep Track Biotechology Master Fund, Ltd. /s/ David Kroin, Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deep Track Biotechnology Master Fund, Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DYNAVAX TECHNOLOGIES CORP 10%+ Owner Common Stock, par value $0.001 per share 15.7M $167M $10.59 Aug 22, 2025 Direct
LB PHARMACEUTICALS INC 10%+ Owner Common Stock 2.69M Sep 12, 2025 Direct
LB PHARMACEUTICALS INC 10%+ Owner Common Stock 667K Sep 12, 2025 By Deep Track Special Opportunities Fund, LP
LB PHARMACEUTICALS INC 10%+ Owner Series C Preferred Stock 0 Sep 12, 2025 Direct

Insider Reports Filed by Deep Track Biotechnology Master Fund, Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LBRX LB PHARMACEUTICALS INC Sep 12, 2025 4 $40M 4 Sep 16, 2025 10%+ Owner
LBRX LB PHARMACEUTICALS INC Sep 10, 2025 0 $0 3 Sep 10, 2025 10%+ Owner
DVAX DYNAVAX TECHNOLOGIES CORP Aug 21, 2025 2 -$22.4M 4 Aug 22, 2025 10%+ Owner
DVAX DYNAVAX TECHNOLOGIES CORP Oct 22, 2024 0 $0 3 Oct 24, 2024 10%+ Owner